nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Infestation—Etoposide—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Ceftaroline fosamil—Renal failure—Etoposide—peripheral nervous system neoplasm	0.00355	0.00355	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00347	0.00347	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00339	0.00339	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Ceftaroline fosamil—Constipation—Topotecan—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Ceftaroline fosamil—Pain—Topotecan—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Ceftaroline fosamil—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Ceftaroline fosamil—Pain—Tretinoin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Ceftaroline fosamil—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Ceftaroline fosamil—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Ceftaroline fosamil—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Ceftaroline fosamil—Pain—Melphalan—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Ceftaroline fosamil—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00322	0.00322	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Ceftaroline fosamil—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Ceftaroline fosamil—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Ceftaroline fosamil—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Ceftaroline fosamil—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Ceftaroline fosamil—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Ceftaroline fosamil—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Ceftaroline fosamil—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Ceftaroline fosamil—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Ceftaroline fosamil—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Ceftaroline fosamil—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Ceftaroline fosamil—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Ceftaroline fosamil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Ceftaroline fosamil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Ceftaroline fosamil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Ceftaroline fosamil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Ceftaroline fosamil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Ceftaroline fosamil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Ceftaroline fosamil—Rash—Topotecan—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Headache—Topotecan—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Rash—Tretinoin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Ceftaroline fosamil—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Ceftaroline fosamil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Headache—Tretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Constipation—Vincristine—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Pain—Vincristine—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Rash—Melphalan—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Ceftaroline fosamil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Nausea—Topotecan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Ceftaroline fosamil—Nausea—Melphalan—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Ceftaroline fosamil—Pain—Cisplatin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Ceftaroline fosamil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Pain—Etoposide—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Constipation—Etoposide—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftaroline fosamil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Rash—Vincristine—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Ceftaroline fosamil—Headache—Vincristine—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Ceftaroline fosamil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Nausea—Vincristine—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Ceftaroline fosamil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Rash—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Ceftaroline fosamil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Rash—Etoposide—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Ceftaroline fosamil—Headache—Etoposide—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Nausea—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000977	0.000977	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000945	0.000945	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000945	0.000945	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000914	0.000914	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000884	0.000884	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00088	0.00088	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000854	0.000854	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000845	0.000845	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000821	0.000821	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000818	0.000818	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000814	0.000814	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000813	0.000813	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000809	0.000809	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00079	0.00079	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00076	0.00076	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000749	0.000749	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
